Dolby Laboratories Stock Hits 52-Week Low at $67.10

Dolby Laboratories, Inc. has reached a new 52-week low, trading at USD 67.10 as of October 22, 2025. This marks a significant decline for the small-cap software company, which has seen its stock price decrease by 15.05% over the past year, contrasting sharply with the S&P 500's performance of 15.06% during the same period.
The company's market capitalization stands at USD 7,024 million, with a price-to-earnings (P/E) ratio of 27.00. Despite a dividend yield of 1.80%, Dolby's financial metrics indicate a challenging environment. The company has reported a decline in pre-tax profit and net profit for the most recent quarter, with figures falling by 33.05% and 31.39%, respectively. Additionally, cash and equivalents have reached a low of USD 1,507.67 million.

Dolby Laboratories has a return on equity of 10.42% and a price-to-book ratio of 2.70, suggesting an attractive valuation relative to its peers. However, the company has experienced flat growth in net sales and operating profit over the last five years, raising concerns about its long-term performance. High institutional holdings at 100% reflect a strong interest from sophisticated investors, who have increased their stake by 1.89% in the previous quarter.